Blood Thinners and Vitreous Hemorrhage: What the Evidence Actually Shows
Blood Thinners and Bleeding Inside the Eye at a Glance
Bleeding inside the eye is usually painless. It can still be urgent. Call your eye doctor the same day, or seek urgent care, if you notice any of these in one eye:
- A sudden shower of new floaters or dark specks
- A red or smoky haze over your vision
- New flashing lights
- A dark curtain or shadow in your side vision
- A sudden drop in vision
These signs can come from a torn retina. A tear found at a prompt dilated exam can be treated before the retina lifts1. That is why speed helps. Do not stop your blood thinner while you wait to be seen. That choice belongs to the doctor who prescribed it.
Vitreous hemorrhage means blood has leaked into the clear gel that fills the back of your eye. Something opens a vessel first, most often a tugging vitreous or an abnormal blood vessel of diabetic disease. A clinical review published by the American Academy of Ophthalmology reports that anticoagulation of any type has not been identified as a risk factor for vitreous hemorrhage2.
The research is genuinely mixed. Some evidence points to a modest increase in the chance that a vitreous detachment bleeds, other evidence finds no increase at all, and none of it changes what you should do next.
Do not stop or reduce a blood thinner on your own because of an eye symptom. A systematic review of 22 studies found the literature nearly unanimous in recommending that people stay on their antiplatelet or anticoagulant medicines even around eye surgery, because stopping them exposes patients to serious clotting events, while continuing them did not increase bleeding complications that needed a second operation3.
The stroke or clot the medicine prevents is a larger threat than the eye bleed it may have made worse. If you want the medicine reviewed, that is a fair conversation to have with the doctor who prescribed it, not a decision to make alone in a waiting room.
What a Vitreous Hemorrhage Is
The back of your eye is filled with a clear gel called the vitreous, which has no blood vessels of its own. When blood enters it, from the retina behind it or from abnormal vessels growing into it, the gel has no quick way to clear it. The blood scatters light before it reaches the retina, which is why vision looks hazy, smoky, or spotted rather than simply dim.
Spontaneous vitreous hemorrhage affects roughly 7 of every 100,000 people a year. In one series, proliferative diabetic retinopathy accounted for about 43 of every 100 cases, retinal detachment about 11 of every 100, retinal vein occlusion about 3 of every 100, and macular degeneration about 2 of every 100, while injury is the leading cause in people under 404.
Every item on that list is an eye condition rather than a medicine. That is where your doctor looks first, because it is where the treatable problem usually is.
What Causes Bleeding Into the Vitreous
Three situations account for most cases: a vitreous detachment that tears a small retinal vessel as the gel pulls away, diabetic eye disease in which fragile new vessels grow and bleed, and injury to the eye. Blocked retinal veins, sickle cell disease, and bleeding from macular degeneration make up much of the rest.
As the gel shrinks with age, it peels off the retina. Where it sticks too firmly, it can pull hard enough to tear the retina, and a torn retina often takes a blood vessel with it. That is the sequence behind most sudden, painless eye bleeds in people who do not have diabetes.
This is also why an eye bleed is treated as urgent rather than merely annoying. The blood itself will clear. A tear underneath it will not, and it needs finding.
In advanced diabetic retinopathy, the retina grows new vessels to compensate for poor blood supply. These vessels are fragile and grow in the wrong place, on the surface of the retina and into the gel. They leak and bleed with little provocation. This is the single largest cause of bleeding into the gel4, and unlike a torn vessel it reflects a disease process that needs its own treatment.
These medicines do not damage blood vessels or make new ones grow. They slow clotting, so a vessel already torn or already leaking may bleed a little more before it seals. That is reasoning about mechanism rather than a measured effect: a blood thinner could change the size of a bleed without being the reason it happened. What the studies actually found is next.
What the Research Says About Blood Thinners
In a retrospective review of 336 eyes with an acute vitreous detachment, vitreous hemorrhage was present in about 43 of every 100 people taking aspirin, clopidogrel, or warfarin, compared with about 31 of every 100 not taking them. Retinal tears were found in about 46 of every 100 eyes that had bleeding versus about 27 of every 100 without it, and no statistically significant link was demonstrated between anticoagulant use and the presence of a retinal tear or detachment5.
Read the two halves separately. People on these medicines were more likely to arrive with blood in the eye. The study did not show them to be more likely to have the torn retina that actually threatens sight, though a review this size cannot rule out a small difference.
The strongest single piece of evidence points the other way, and it is a randomized trial rather than a chart review. Among 3,711 people with diabetic retinopathy assigned to either 650 milligrams of aspirin a day or a placebo, aspirin did not increase how often bleeding into the gel or in front of the retina occurred, and did not increase how severe it was or how long it lasted6.
That trial studied the group most people worry about, people whose retinas were already prone to bleeding, and found no increase.
If bleeding inside the eye is on your mind, the type of medicine may matter more than whether you take one. A meta-analysis of 12 randomized trials including 102,627 people found that direct oral anticoagulants were associated with roughly one-fifth less bleeding inside the eye than warfarin7. That compares two medicines with each other; it is not an argument against taking one.
Which anticoagulant suits you is decided on your clot risk, your kidney function, and your other medicines. Eye bleeding is one small input, and your prescriber is the person who weighs it.
An honest summary has three parts. A blood thinner may modestly raise the chance that a vitreous detachment shows up with blood in it. The best randomized evidence, for aspirin, found no increase. And a clinical review published by the American Academy of Ophthalmology reports that anticoagulation of any type has not been identified as a risk factor, and that these medicines are generally not stopped once a hemorrhage develops2.
Where all three agree is the practical part. A bleed on a blood thinner is examined the same way, treated the same way, and followed the same way as any other bleed, and the medicine keeps doing its job while that happens.
Symptoms and Warning Signs
Vitreous hemorrhage usually causes floaters, haziness, cobwebs, or the sense of shadows, and it is usually painless8. It is typically one-sided, and a red tint over the vision is another common description9. A small bleed may look like a scatter of dark dots. A large one can reduce vision to shapes and light.
Blood settles under gravity, which is why observation is paired with keeping the head elevated, so the blood drops below the line of sight10. Many people describe vision as haziest on waking, when the blood has spread out overnight, and clearer later in the day.
These shifts are expected and are not a sign that anything new has gone wrong. What matters is the direction over weeks, and your doctor tracks that at follow-up.
Some symptoms suggest the retina itself is involved rather than just the gel in front of it. A dark curtain rising or spreading from one side, a fixed area of missing vision that does not drift with your eye, and vision that keeps worsening after the first day all belong in that group. Pain or redness, which a simple vitreous bleed does not usually cause, is another reason to be seen promptly rather than to wait.
How a Vitreous Hemorrhage Is Diagnosed
The whole point of the visit is to find out whether the retina is torn. About 50 to 70 of every 100 people whose vitreous detachment comes with bleeding turn out to have a retinal tear, compared with about 7 to 12 of every 100 whose detachment has no bleeding11. Blood in the eye therefore raises the stakes of the exam considerably.
That is a high number, and it is exactly why the appointment is worth pushing for. A tear found at that exam can be treated, which is the step that keeps the retina from detaching1.
When blood blocks the view of the back of the eye, a B-scan ultrasound is used to check whether the retina is still attached10. The probe rests on your closed eyelid over a little gel and takes a few minutes. It does not hurt and needs no needle or dye. It cannot show a small tear the way a direct look can, so the exam is repeated as blood clears.
Once the retina is accounted for, attention turns to why the bleed happened. Your doctor will examine the other eye, since diabetic changes are often present in both. Blood sugar and blood pressure readings, and sometimes a retinal scan or a dye study of its circulation, help identify diabetic disease or a blocked vein. A review of your medicines is part of this, as information rather than a plan to stop anything.
Treatment and What Happens Next
If the retina is attached, the usual first step is to let the eye clear itself. Blood leaves the gel at a rate of roughly one hundredth of it per day, and while the retina is attached this is managed as an outpatient9. Conservative management includes observation with the head kept elevated, which helps the blood settle below the line of sight10.
That clearance rate is why doctors talk in weeks and months rather than days. Slow is normal here, and it does not mean the eye is failing to heal.
Clearing blood is only half the job. A retinal tear is sealed with laser or freezing treatment, diabetic new vessels are treated with laser or with injections that shrink them, and a blocked vein is managed on its own terms. Without this step the eye is likely to bleed again, which is why the cause matters more than the blood.
Vitrectomy, an operation that removes the gel and the blood in it, is indicated when there is a retinal detachment, an infection inside the eye, or a hemorrhage that has not cleared over a long period10. Surgeons also weigh operating sooner when the blood blocks treatment the retina needs, or when the other eye sees poorly and waiting would leave you unable to function.
Timing is often a genuine judgment call rather than a fixed rule, which makes it a reasonable thing to ask your surgeon to explain in your own case.
The usual answer is that nothing changes. Anticoagulants of any type, including aspirin, warfarin, and clopidogrel, are generally not discontinued once a vitreous hemorrhage has developed2. Even where eye surgery is planned, the literature is nearly unanimous that these medicines should be continued, because stopping them risks serious clotting events without preventing bleeding complications that need a second operation3.
If your eye doctor and your prescriber do want to review the medicine, that is a conversation between them and you, with your clot risk on the table alongside your eye. It is not something to act on unilaterally.
Risks, Complications, and the Realistic Outlook
The main risk in a vitreous hemorrhage is not the blood. It is an untreated retinal tear underneath it, which can let fluid pass behind the retina and detach it. A detached retina needs surgery and is harder to repair than a tear that was sealed early. That is the whole reason for the urgency, and it is also why follow-up appointments continue after the initial scare passes.
Blood that stays a long time, or that keeps coming back, can raise the pressure inside the eye when red cells and their debris block its drainage, can leave iron deposits in eye tissue, can lead to scar tissue on the retinal surface, and in infants can hold back visual development, which is why early surgery is used in babies12. Each of these is a reason for follow-up rather than a reason for alarm, since each is manageable once someone is watching for it.
The outlook depends far more on the cause than on the blood. Conditions that do not cause repeated bleeding usually have a good outlook, while eyes bleeding from diabetic retinopathy do less well13. That is why treatment aims at the vessels rather than the blood. None of this predicts your own result, which depends on findings only your own examination can show.
When to See a Doctor
Call your eye doctor the same day, or seek urgent care if you cannot reach them, for any of these:
- A sudden shower of floaters, dark specks, or a red or smoky haze
- New flashes of light in one eye
- A dark curtain or shadow spreading across your vision
- A sudden drop in vision, or vision that keeps worsening
- Eye pain or redness alongside any of the above
The guidance is a prompt dilated examination, because that is how a retinal break is found and treated, with a repeat examination within about six weeks when there is blood or pigment in the gel or visible pulling on the retina1. Keep taking your blood thinner while you arrange the visit.
Expect more than one appointment. Early on, the exam and an ultrasound answer whether the retina is attached. As blood clears, your doctor repeats the examination to see the retina directly, because a small tear can hide behind blood on the first visit. If you have diabetes, follow-up also covers treating the vessels that bled.
A vitreous hemorrhage is managed by an ophthalmologist, usually a retina specialist, since the treatments are laser, injections, and vitrectomy. Your optometrist or family doctor may be who you reach first and can arrange the referral. The doctor who prescribes your blood thinner belongs on the team too, because any question about that medicine is theirs to answer.
Common Questions About Blood Thinners and Eye Bleeding
No, not on your own, and eye specialists generally will not ask you to. An eye bleed usually clears and is treatable. The clot or stroke your medicine is preventing is the bigger danger, and that risk returns quickly once doses are skipped. Bring the tablets or a list to your appointment so the eye team can see exactly what you take. Any change is your prescriber's call, made with them, not a decision to make in the waiting room.
Almost certainly not by itself. Blood thinners do not damage retinal vessels or make new ones grow. Something else opened a vessel, usually a vitreous detachment tearing the retina, diabetic new vessels, or an injury. A blood thinner can make an existing leak larger or slower to stop. Finding and treating the underlying cause matters far more than the medicine, and it is what your appointment is for.
The best evidence says no. In a randomized trial of 3,711 people with diabetic retinopathy, those assigned 650 milligrams of aspirin a day were no more likely to have bleeding into the gel or in front of the retina than those on placebo, and the bleeds were not more severe or longer lasting. One retrospective study grouping aspirin with clopidogrel and warfarin did find more bleeding, so the picture is mixed, but the randomized evidence for aspirin is reassuring.
There is some evidence favoring the newer ones. A meta-analysis of 12 randomized trials in 102,627 people found direct oral anticoagulants were linked to roughly one-fifth less bleeding inside the eye than warfarin. That is worth knowing, but it is not by itself a reason to switch. Which anticoagulant fits you depends on your clot risk, your kidneys, and your other medicines, and that decision belongs with your prescriber.
Usually weeks to months rather than days. Blood leaves the gel at roughly one hundredth of its volume per day, so a dense bleed takes a long time to clear on its own. Vision often improves in stages, and is commonly worse on waking because blood spreads out overnight. If it has not cleared after a prolonged period, or if the retina needs treatment hidden behind the blood, surgery to remove the gel becomes an option.
Treat it as urgent. The bleeding itself is rarely the danger, but among people whose vitreous detachment comes with bleeding, about 50 to 70 of every 100 turn out to have a retinal tear, against about 7 to 12 of every 100 without bleeding. A tear found promptly can usually be treated in the office. A tear left alone can progress to a detached retina, which is much harder to repair well.
More Questions About Vitreous Hemorrhage
Usually not in the short term, which is why watching and waiting is a normal plan. Over longer periods, blood that does not clear can raise the pressure inside the eye when cells and debris block its drainage, can leave iron deposits in eye tissue, and in infants can hold back visual development. These are the reasons your doctor sets follow-up appointments rather than sending you away, and they are manageable when someone is watching for them.
Ask your own eye doctor, because the answer depends on what they found. Advice commonly includes keeping the head elevated, including when sleeping, so blood settles below the line of sight. Restrictions on activity are usually about protecting a retinal tear or a repair rather than the blood itself. If a tear or detachment was found, expect more specific instructions, and follow those rather than general advice.
That depends on the cause. A bleed from a retinal tear that has been sealed is unlikely to repeat from that tear. Bleeding from diabetic new vessels tends to recur until those vessels are treated with laser or injections, which is why that treatment is the real answer rather than waiting for blood to clear. Your doctor can tell you which situation you are in.
No, though it is a common cause and worth ruling out. Diabetic retinopathy is the single most frequent reason for bleeding into the gel, so blood sugar testing is a standard part of the workup even in people with no diabetes diagnosis. Plenty of bleeds have nothing to do with diabetes and come instead from a vitreous detachment tearing a vessel, an injury, or a blocked retinal vein.
A few focused questions make the visit more useful. Consider asking:
- Could you see my retina, and is there a tear or detachment?
- What do you think caused the bleeding in my eye?
- When do I need to be examined again, and what would make me call sooner?
- Should anything about my blood thinner change, and who decides that?
- How should I position my head, and are there activities to avoid for now?
- At what point would you consider surgery to remove the blood?
- American Academy of Ophthalmology, Preferred Practice Pattern (2025). Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern.
- EyeNet Magazine, American Academy of Ophthalmology, Berdahl JP & Mruthyunjaya P (2007). Vitreous Hemorrhage: Diagnosis and Treatment.
- Life (Basel), Confalonieri F et al., 2023;13(6):1362, PMC10302284 (2023). Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review.
- StatPearls, NCBI Bookshelf, Jena S & Tripathy K (2023). Vitreous Hemorrhage (StatPearls), epidemiology and etiology.
- Retina, Witmer MT & Cohen SM, 2013;33(3):621-6, PMID 23108264 (2013). Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment.
- Archives of Ophthalmology, Early Treatment Diabetic Retinopathy Study Research Group, PMID 7826294 (1995). Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus (ETDRS report no. 20).
- JAMA Ophthalmology, PMC5710315 (2017). Risk of Intraocular Bleeding With Novel Oral Anticoagulants Compared With Warfarin: A Systematic Review and Meta-analysis.
- StatPearls, NCBI Bookshelf, Jena S & Tripathy K (2023). Vitreous Hemorrhage (StatPearls), presentation.
- EyeNet Magazine, American Academy of Ophthalmology, Berdahl JP & Mruthyunjaya P (2007). Vitreous Hemorrhage: Diagnosis and Treatment (clinical course).
- StatPearls, NCBI Bookshelf, Jena S & Tripathy K (2023). Vitreous Hemorrhage (StatPearls), evaluation and management.
- StatPearls, NCBI Bookshelf, Ahmed F & Tripathy K (2023). Posterior Vitreous Detachment (StatPearls), retinal tear risk.
- StatPearls, NCBI Bookshelf, Jena S & Tripathy K (2023). Vitreous Hemorrhage (StatPearls), complications.
- StatPearls, NCBI Bookshelf, Jena S & Tripathy K (2023). Vitreous Hemorrhage (StatPearls), prognosis.